ZM2-14276-73673
4 vaccinations
3 coded responses
35 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 275 / NC
- Registered
- 2021-03-02
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Hispanic or Latino
Registered dependents
AXU-75579-65330
Child or adolescent in my care · Female · 2022-11-22
Timeline
-
2021-03-01
Dose 1 — Pfizer-BioNTech
-
2021-03-02
Registered in v-safe
-
2021-03-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-15
- 2021-03-22
-
2021-03-24
Dose 2 — Pfizer-BioNTech
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-03-28
- 2021-03-31
- 2021-04-07
- 2021-04-16
- 2021-04-21
- 2021-04-28
- 2021-05-05
-
2021-06-23
Survey response — 3 months, dose 2MedDRA: Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: PregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-23
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-06-25
- 2021-09-22
-
2021-10-12
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-10-13
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-14
- 2021-10-15
- 2021-10-17
- 2021-10-19
- 2021-11-02
- 2021-11-09
- 2021-11-16
-
2022-01-11
Survey response — 3 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-01-11
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-01-12
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-04-12
-
2022-10-14
Survey response — 12 months, dose 3MedDRA: Exposure to communicable disease, Heavy menstrual bleeding, Migraine, Viral infection — Feeling: Fair · Be unable to work or attend schoolFree text: Today I have some virus transmitted from my daughter. I have migraines and heavy periods that last almost a week, before they lasted 4 days top.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-22
Dose 4 — Pfizer-BioNTech
-
2022-11-22
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
- 2022-11-24
- 2022-11-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-01 | Pfizer-BioNTech | |
| 2 | 2021-03-24 | Pfizer-BioNTech | |
| 3 | 2021-10-12 | Pfizer-BioNTech | Flu |
| 4 | 2022-11-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-23 | Successful | Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-01-11 | Successful 2022-01-12 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 9 — 3 months, dose 2
Symptoms: Pregnancy
Release 10 — 3 months, dose 3
Symptoms: Covid
Release 12 — 12 months, dose 3
Symptoms: Today I have some virus transmitted from my daughter. I have migraines and heavy periods that last almost a week, before they lasted 4 days top.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Exposure to communicable disease | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release